The Role of Reactive Oxygen Species in Colorectal Cancer Initiation and Progression: Perspectives on Theranostic Approaches
Open Access
Abstract
Altered levels of reactive oxygen species (ROS) are recognized as one of the key factors in mediating tumor cell survival in the tissue microenvironment, where they play a role in the initiation, progression and recurrence/relapse of colorectal cancer (CRC). Tumor cells can adapt to oxidative stress (OS) using genetic or metabolic reprogramming in the long or short term. In addition, tumor cells defend themselves through positive regulation of antioxidant molecules, enhancing ROS-driven proliferation. Balanced oxidative eustress levels can influence chemotherapy resistance, allowing tumor cells to survive treatment. Secondary effects of chemotherapy include increased ROS production and redox stress, which can kill cancer cells and eliminate drug resistance. Anticancer treatments based on manipulating ROS levels could represent the gold standard in CRC therapy. Therefore, exploring the modulation of the response to OS in deregulated signaling pathways may lead to the development of new personalized CRC treatments to overcome therapy resistance. In this review, we explore the role of ROS in the initiation and progression of CRC and their diagnostic implications as biomarkers of disease. Furthermore, we focused on the involvement of ROS in different CRC therapeutic options, such as surgery, radiotherapy, theranostic imaging, chemotherapy and immunotherapy and other precision medicine approaches.Keywords
Funding Information
- Gitana Maria Aceto and Roberto Cotellese FAR-GRANT 2021 University of Chieti–Pescara Funds
This publication has 186 references indexed in Scilit:
- Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulationApoptosis, 2023
- Reactive oxygen species in cancer: a paradox between pro- and anti-tumour activitiesCancer Chemotherapy and Pharmacology, 2020
- The multifaceted role of reactive oxygen species in tumorigenesisCellular and Molecular Life Sciences, 2020
- The Role of the Microbiome in Cancer Initiation and Progression: How Microbes and Cancer Cells Utilize Excess Energy and Promote One Another’s GrowthCurrent Nutrition Reports, 2019
- Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological dysregulated pathwaysJournal of Cellular Physiology, 2018
- Reactive oxygen species and colorectal cancerJournal of Cellular Physiology, 2018
- Effect of surgical stress on nuclear and mitochondrial DNA from healthy sections of colon and rectum of patients with colorectal cancerJournal of Biosciences, 2011
- HFE C282Y homozygotes are at increased risk of breast and colorectal cancer†Hepatology, 2010
- Carbon dioxide directly suppresses spontaneous migration, chemotaxis, and free radical production of human neutrophilsSurgical Endoscopy, 2007
- PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2European Journal of Immunology, 2002